Last reviewed · How we verify
Levulose (FRUCTOSE)
At a glance
| Generic name | FRUCTOSE |
|---|---|
| Drug class | fructose |
| Target | Glycine receptor subunit alpha-1 |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Defining Objective Markers of Compliance for Dietary Therapies in IBS (NA)
- Dose-dependent FODMAP Reintroduction in IBS (NA)
- Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP (EARLY_PHASE1)
- Effects of Dual-Source Carbohydrate Intake and Liver Glycogen Repletion After Overnight Fasting. (NA)
- Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study (PHASE4)
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity (PHASE2)
- Monocyte Priming When Consuming a Western Diet (NA)
- Fructose Intestinal Gluconeogenesis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |